266 related articles for article (PubMed ID: 2934633)
41. LAV/HTLV-III infection in children of African origin: experience in Belgium.
Jonckheer T; Levy J; Van de Perre P; Thiry L; Henrivaux P; Sacré JP; Schepens G; Mees N; Dab I; Taelman H
Eur J Pediatr; 1986 Dec; 145(6):511-6. PubMed ID: 2949977
[TBL] [Abstract][Full Text] [Related]
42. Recommendations for providing dialysis treatment to patients infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1986 Oct; 105(4):558-9. PubMed ID: 3019202
[TBL] [Abstract][Full Text] [Related]
43. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
[TBL] [Abstract][Full Text] [Related]
44. Coincidental appearance of LAV/HTLV-III antibodies in hemophiliacs and the onset of the AIDS epidemic.
Evatt BL; Gomperts ED; McDougal JS; Ramsey RB
N Engl J Med; 1985 Feb; 312(8):483-6. PubMed ID: 2982095
[TBL] [Abstract][Full Text] [Related]
45. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
[TBL] [Abstract][Full Text] [Related]
46. Isolation of human immune deficiency virus from African AIDS patients and from persons without AIDS or IgG antibody to human immune deficiency virus.
McCormick JB; Krebs JW; Mitchell SW; Feorino PM; Getchell JP; Odio W; Kapita B; Quinn TC; Piot P
Am J Trop Med Hyg; 1987 Jan; 36(1):102-6. PubMed ID: 2949638
[TBL] [Abstract][Full Text] [Related]
47. Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production.
Murray HW; Hillman JK; Rubin BY; Kelly CD; Jacobs JL; Tyler LW; Donelly DM; Carriero SM; Godbold JH; Roberts RB
N Engl J Med; 1985 Dec; 313(24):1504-10. PubMed ID: 3934537
[TBL] [Abstract][Full Text] [Related]
48. The AIDS epidemic.
Landesman SH; Ginzburg HM; Weiss SH
N Engl J Med; 1985 Feb; 312(8):521-5. PubMed ID: 2982097
[TBL] [Abstract][Full Text] [Related]
49. Immunodeficiency in female sexual partners of men with the acquired immunodeficiency syndrome.
Harris C; Small CB; Klein RS; Friedland GH; Moll B; Emeson EE; Spigland I; Steigbigel NH
N Engl J Med; 1983 May; 308(20):1181-4. PubMed ID: 6221192
[TBL] [Abstract][Full Text] [Related]
50. Spectrum of human T-cell lymphotropic virus type III infection in children. Recognition of symptomatic, asymptomatic, and seronegative patients.
Pahwa S; Kaplan M; Fikrig S; Pahwa R; Sarngadharan MG; Popovic M; Gallo RC
JAMA; 1986 May; 255(17):2299-305. PubMed ID: 3007791
[TBL] [Abstract][Full Text] [Related]
51. Immunopathogenesis of the acquired immunodeficiency syndrome.
Bowen DL; Lane HC; Fauci AS
Ann Intern Med; 1985 Nov; 103(5):704-9. PubMed ID: 2996403
[TBL] [Abstract][Full Text] [Related]
52. Quantitative estimation by a standardized enzyme-linked immunosorbent assay of human T-cell lymphotropic virus type I antibodies in adult T-cell leukemia and acquired immune deficiency syndrome.
Halbert SP; Poiesz B; Friedman-Kien AE; Montagna R; Blattner WA; Anken M
J Clin Microbiol; 1986 Feb; 23(2):212-6. PubMed ID: 3009530
[TBL] [Abstract][Full Text] [Related]
53. Acquired immunodeficiency syndrome in infants.
Scott GB; Buck BE; Leterman JG; Bloom FL; Parks WP
N Engl J Med; 1984 Jan; 310(2):76-81. PubMed ID: 6606781
[TBL] [Abstract][Full Text] [Related]
54. Risk of nosocomial infection with human T-cell lymphotropic virus type III/lymphadenopathy-associated virus in a large cohort of intensively exposed health care workers.
Henderson DK; Saah AJ; Zak BJ; Kaslow RA; Lane HC; Folks T; Blackwelder WC; Schmitt J; LaCamera DJ; Masur H
Ann Intern Med; 1986 May; 104(5):644-7. PubMed ID: 3963663
[TBL] [Abstract][Full Text] [Related]
55. Three-year prospective study of HTLV-III/LAV infection in homosexual men.
Weber JN; Wadsworth J; Rogers LA; Moshtael O; Scott K; McManus T; Berrie E; Jeffries DJ; Harris JR; Pinching AJ
Lancet; 1986 May; 1(8491):1179-82. PubMed ID: 2871421
[TBL] [Abstract][Full Text] [Related]
56. Restricted IgG subclass responses to HTLV-III/LAV and to cytomegalovirus in patients with AIDS and lymphadenopathy syndrome.
Sundqvist VA; Linde A; Kurth R; Werner A; Helm EB; Popovic M; Gallo RC; Wahren B
J Infect Dis; 1986 May; 153(5):970-3. PubMed ID: 3009638
[No Abstract] [Full Text] [Related]
57. Acquired immune deficiency syndrome in childhood: impaired production of interleukin-2 by HIV (LAV/HTLV III) infected patients.
Maccario R; Aricó M; Ugazio A; Plebani A; Montagna D; Avanzini A; Marseglia G; Caselli D; Burgio G
Infection; 1987; 15(2):99-104. PubMed ID: 2954915
[TBL] [Abstract][Full Text] [Related]
58. Non-Hodgkin's lymphoma, HTLV-III/LAV, and HTLV-III/LAV antibody in the wife of a man with transfusion-acquired AIDS.
Duncan ED; Miller HJ; McKeever WP
Am J Med; 1986 Nov; 81(5):898-900. PubMed ID: 3640579
[TBL] [Abstract][Full Text] [Related]
59. The epidemiology and prevention of the acquired immunodeficiency syndrome.
Curran JW
Ann Intern Med; 1985 Nov; 103(5):657-62. PubMed ID: 2996395
[TBL] [Abstract][Full Text] [Related]
60. Epidemiological evidence that HTLV-III is the AIDS agent.
Goedert JJ; Gallo RC
Eur J Epidemiol; 1985 Sep; 1(3):155-9. PubMed ID: 2945735
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
